ArticleSleep & breathing = Schlaf & Atmung2026
Association of reduced REM sleep with mortality in adults with coronary artery disease and obstructive sleep apnea in the RICCADSA cohort.
Article in Sleep & breathing = Schlaf & Atmung, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
purposeReduced rapid-eye movement (REM) sleep has been linked to increased mortality in the general population. We investigated whether diminished REM sleep is associated with higher mortality in adults with coronary artery disease (CAD) and obstructive sleep apnea (OSA).
methodsThis secondary analysis of the RICCADSA trial included 356 revascularized CAD patients with OSA (apnea-hypopnea index [AHI] ≥ 15 events/h) and total sleep time (TST) ≥ 240 min on baseline polysomnography. Reduced REM sleep was defined as the lowest quartile of REM percentage. Cox proportional hazards models assessed the association between reduced REM sleep and mortality over a median 4.7-year follow-up.
resultsThe lowest REM quartile corresponded to 8.7% of TST. Participants with reduced REM sleep (n = 86) were older (66.0 ± 8.1 vs. 63.0 ± 8.0 years; p = 0.035), had higher BMI (29.8 ± 4.6 vs. 28.7 ± 3.8 kg/m²; p = 0.010), shorter TST (369 ± 77 vs. 497 ± 69 min; p < 0.001), less slow-wave sleep (5.2 ± 7.0% vs. 8.1 ± 10.0%; p = 0.007), and higher AHI (54.4 ± 26.3 vs. 35.6 ± 20.1 events/h; p < 0.001) than those with REM ≥ 8.7% (n = 270). Mortality was 12.8% in the reduced REM group versus 4.4% in the higher REM group (p = 0.006). Reduced REM sleep independently predicted mortality (hazard ratio 2.39; 95% CI 1.03-5.56; p = 0.043) after adjustment for age, sex, BMI, and CPAP allocation. Further adjustment for TST, slow-wave sleep, baseline AHI, coronary bypass surgery, atrial fibrillation, and REM-AHI interaction did not alter the association.
conclusionsReduced REM sleep independently predicted higher all-cause mortality in revascularized CAD patients with OSA. Identifying diminished REM sleep may help identify particularly vulnerable patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.